Measurement of HPRT mutations in splenic lymphocytes and haemoglobin adducts in erythrocytes of Lewis rats exposed to ethylene oxide

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 431, Issue 2, 1999, Pages 397-415

  Tates, Ad D ^a   Van Dam, Fred J ^a   Natarajan, Adayapalam T ^a,b   Van Teylingen, Corrie M M ^a   De Zwart, Frans A ^a   Zwinderman, Ailko H ^a   Van Sittert, Nico J ^c   Nilsen, Asbjørn ^d   Nilsen, Odd G ^d   Zahlsen, Kolbjørn ^d   Magnusson, Anna Lena ^e   Törnqvist, Margareta ^e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JA Cohen Institute Interuniversity Research Institute for Radiopathology and Radiation Protection   (Netherlands)

^c Leiden University Medical Centre ^*  (Netherlands)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^e STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Ethylene oxide; Haemoglobin adducts; HPRT mutations; Lymphocytes; Rats; Spleen

Indexed keywords

ETHYLENE OXIDE;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL MUTAGENESIS; ERYTHROCYTE; GENE MUTATION; GENETIC ANALYSIS; MALE; MOLECULAR CLONING; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN LYMPHOCYTE;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ANIMALS; CARCINOGENS; CHROMOSOME ABERRATIONS; DNA ADDUCTS; ERYTHROCYTES; ETHYLENE OXIDE; ETHYLNITROSOUREA; GUANINE; HEMOGLOBINS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INJECTIONS, INTRAPERITONEAL; LYMPHOCYTES; MALE; MICRONUCLEUS TESTS; MUTATION; RATS; RATS, INBRED LEW; SISTER CHROMATID EXCHANGE; SPLEEN;

EID: 0033382001     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00182-7     Document Type: Article

References (54)

1. Törnqvist M. Snyder R.et al. Ethylene oxide as a biological reactive intermediate of endogenous origin. Biological Reactive Intermediates. V:1996;275-283 Plenum, New York.
2. Törnqvist M., Ehrenberg L. On cancer risk estimation of urban air pollution. Environ. Health Perspect. 102(4):1994;173-182.
3. Ehrenberg L., Hussain S. Genetic toxicity of some important epoxides. Mutat. Res. 24:1981;1-113.
4. Dellarco V.L., Generoso W.M., Sega G.A., Fowle J.R. III, Jacobson-Kram D. Review of the mutagenicity of ethylene oxide. Environ. Mol. Mutagen. 16:1990;85-103.
5. Tates A.D., Grummt T., Törnqvist M., Farmer P.B., van Dam F.J., van Mossel H., Schoemaker H.M., Osterman-Golkar S., Uebel Ch., Tang Y.S., Zwinderman A.H., Natarajan A.T., Ehrenberg L. Biological and chemical monitoring of occupational exposure to ethylene oxide. Mutat. Res. 250:1991;483-497.
6. Tates A.D., Boogaard P.J., Darroudi F., Natarajan A.T., Caubo M.E., van Sittert N.J. Biological effect monitoring in industrial workers following incidental exposure to high concentrations of ethylene oxide. Mutat. Res. 329:1995;63-77.
7. Natarajan A.T., Preston R.J., Dellarco V., Ehrenberg L., Generoso W., Lewis S., Tates A.D. Ethylene oxide: evaluation of genotoxicity data and an exploratory assessment of genetic risk. Mutat. Res. 330:1995;55-70.
8. Sisk S.C., Pluta L.J., Meyer K.G., Wong B.C., Recio L. Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure. Mutat. Res. 391:1997;153-165.
9. Walker V.E., Skopek T.R. A mouse model for the study of in vivo mutational spectra: sequence specificity of ethylene oxide at the HPRT locus. Mutat. Res. 288:1993;151-162.
10. Walker V.E., Craft T.R., Skopek T.R. Spectrum of ethylene oxide induced mutation in HPRT Exon3 of splenic T-cells from exposed B6C3F1 mice. Environ. Mutagen. 23:1994;72.
11. Walker V.E., Recio L., Sisk S.C., Skopek T.R. Mutagenicity at the HPRT locus of T-cells following inhalation exposures of Big Blue™ mice to ethylene oxide. Toxicologist. 14:1994;318.
12. Walker V.E., Sisk S.C., Upton P.B., Wong B.A., Recio L. In vivo mutagenicity of ethylene oxide at the HPRT locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure. Mutat. Res. 392:1997;211-222.
13. Rhomberg L., Dellarco V.L., Siegel-Scott C., Dearfield K.L., Jacobson-Kram D. Quantitative estimation of the genetic risk associated with the induction of heritable translocations at low-dose exposure: ethylene oxide as an example. Environ. Mol. Mutagen. 16:1990;104-125.
14. Preston R.J., Fennell T.R., Leber A.P., Sielken R.L. Jr., Swenberg J. Reconsideration of the genetic risk assessment for ethylene oxide exposures. Environ. Mol. Mutagen. 26:1995;189-202.
15. Wright A.S. Assessment of heritable mutations - the parallelogram approach. Mutat. Res. 330:1995;13-21.
16. Ehrenberg L. Genetic toxicity of environmental chemicals. Acta Biol. Iugosl., Ser. F Genetika. 6:1974;367-398.
17. L. Ehrenberg, Risk assessment of ethylene oxide and other compounds, in: V.K. McElheny, E. Abrahamson (Eds.), Assessing Chemical Mutagens: The Risk to Humans, Banbury Report No. 1, Cold Spring Harbor, Cold Spring Harbor Laboratory, NY, 1979, pp. 73-88.
18. Kolman A., Segerbäck D., Osterman-Golkar S. Estimation of the cancer risk of genotoxic chemicals by the rad-equivalence approach. Bartsch H., Hemminki K., O'Neill I.K. Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention. International Agency for Research on Cancer. 1988;258-264 Scientific Publication 89, Lyon.
19. Wright A.S., Bradshaw T.K., Watson W.P. Prospective detection and assessment of genotoxic hazards: a critical appreciation of the contribution of L. Ehrenberg. Bartsch H., Hemminki K., O'Neill I.K. Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention. 1988;237-248 IARC Sci. Publ. No. 89, Lyon.
20. Törnqvist M., Segerbäck D., Ehrenberg L. The "rad-equivalence approach" for assessment and evaluation of cancer risks, exemplified by studies of ethylene oxide and ethene. Garner R.C., Farmer P.B., Steel G.T., Wrightt A.S. Human Carcinogen Exposure, Biomonitoring and Risk Assessment. 1991;141-155 IRL Press, Oxford.
21. Lorenti Garcia C., Darroudi F., Tates A.D., Natarajan A.T. Induction and persistence of micronuclei, sister-chromatid exchanges and chromosomal aberrations in splenocytes and bone marrow cells of rats exposed to ethylene oxide. Mutagenesis. 1999;. submitted.
22. N.J. van Sittert, P.J. Boogaard, A.T. Natarajan, A.D. Tates, L.G. Ehrenberg, M.A. Törnqvist, Formation of DNA adducts and induction of mutagenic effects in rats following 4 weeks inhalation exposure to ethylene oxide as a basis for cancer risk assessment. Mutat. Res. Special Issue, "New Frontiers 2000", in press.
23. Segerbäck D. Reaction products in haemoglobin and DNA after in vitro treatment with ethylene oxide and N-(2-hydroxyethyl)-N-nitrosourea. Carcinogenesis. 11:1990;307-312.
24. Walseth F., Nilsen O.G. Phthalate esters: II. Effect of inhaled dibutylphthalate on cytochrome P450 mediated metabolism in rat liver and lung. Arch. Toxicol. 55:1984;132-136.
25. Zahlsen K., Nilsen A., Eide I., Nilsen O.G. Accumulation and distribution of aliphatic (n-nonane), aromatic (1,2,4-trimethylbenzene) and naphthenic (1,2,3-trimethylcyclohexane) in the rat after repeated inhalation. Pharmacol. Toxicol. 67:1990;436-440.
26. Tates A.D., van Dam F.J., van Teijlingen C.M.M., de Zwart F.A., Zwinderman A.H. Comparison of induction of HPRT mutations by 1,3-butadiene and/or its metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane in lymphocytes from spleen of adult male mice and rats in vivo. Mutat. Res. 397:1998;21-37.
27. van Dam F.J., Natarajan A.T., Tates A.D. Use of a T-lymphocyte clonal assay for determining HPRT mutant frequencies in individual rats. Mutat. Res. 271:1992;231-242.
28. O'Neill J.P., McGinnes M.J., Berman J.K., Sullivan L.M., Nicklas J.A., Albertini R.J. Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutation frequency in humans. Mutagenesis. 2:1987;87-94.
29. Törnqvist M., Mohrer J., Jensen S., Ehrenberg L. Monitoring of environmental cancer initiators through haemoglobin adducts by a modified Edman degradation method. Anal. Biochem. 154:1986;255-266.
30. Törnqvist M. Epoxide adducts to N-terminal valine of haemoglobin. Everse J., Vandegriff K.D., Winslow R.W. Haemoglobins: B. Biochemical and Analytical Methods. Methods in Enzymology. 231:1994;650-657 Academic Press, New York.
31. Mowrer J., Törnqvist M., Jensen S., Ehrenberg L. Modified Edman degradation applied to haemoglobin for monitoring occupational exposure to alkylating agents. Toxicol. Environ. Chem. 11:1986;215-231.
32. Tareke E., Golding B.T., Small R.D., Törnqvist M. Haemoglobin adducts from isoprene and isoprene monoepoxides. Xenobiotica. 28:1998;663-672.
33. Ehrenberg L., Moustacchi E., Osterman-Golkar S., Ekman G. Dosimetry of genotoxic agents and dose relationships of their effects. Mutat. Res. 123:1983;121-182.
34. Granath F.N., Vaca C.E., Ehrenberg L.G., Törnqvist M.A. Cancer risk estimation of genotoxic chemicals based on target dose and a multiplicative model. Risk Analysis. 19:1999;309-320.
35. Granath F., Ehrenberg L., Törnqvist M. Degree of alkylation of macromolecules in vivo from variable exposure. Mutat. Res. 284:1992;297-306.
36. Cole J., Green M.H.L., James S.E., Henderson L., Cole H. Human population monitoring: further assessment of factors influencing measurements of thioguanine-resistant mutant frequency in circulating T-lymphocytes. Mutat. Res. 204:1988;493-507.
37. Tates A.D., van Dam F.J., van Mossel H., Schoemaker H., Thijssen J.C.P., Woldring V.M., Zwinderman K.A.H., Natarajan A.T. Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from 5 control populations. Mutat. Res. 253:1991;199-213.
38. Kolman A., Bohušová T., Lambert B., Simons J.W.I.M. Induction of 6-thioguanine-resistant mutants in human diploid fibroblasts in vitro with ethylene oxide. Environ. Mol. Mutagen. 19:1992;93-97.
39. NTP Chemical Repository, Radian, 1991.
40. Ehrenberg L., Hällström T. Haematologic studies on persons occupationally exposed to ethylene oxide. Radio Sterilization of Medical Products. 1967;327-334 STI/PUB/157, IAEA, Vienna.
41. Walker V.E., Jones I.M., Crippen T.L., Meng Q., Walker D.M., Bauer M.J., A.A.Reilly A.D., Tates A.D., Nakamura J., Upton P.B., Skopek T.R. Relationships between exposure, cell loss and proliferation, and manifestation of HPRT mutant T-cells following treatment of preweanling, weanling, and adult male mice with N-ethyl-N-nitrosourea. Mutat. Res. 431:1999;371-388.
42. Walker V.E., MacNeela J.P., Swenberg J.A., Turner M.J. Jr., Fennell T.R. Molecular dosimetry of ethylene oxide: formation and persistence of N-(2-hydroxyethyl)valine in haemoglobin following repeated exposures of rats and mice. Cancer Res. 52:1992;4320-4327.
43. Osterman-Golkar S., Farmer P.B., Segerbäck D., Bailey E., Calleman C.J., Svensson K., Ehrenberg L. Dosimetry of ethylene oxide in the rat by quantitation of alkylated histidine in haemoglobin. Teratogen. Carcinogen. Mutagen. 3:1983;395-405.
44. Lumb W.V. Small Animal Anaesthesia. 1963;40-41 Lea and Febiger, Philadelphia, PA.
45. Johanson G., Filser J.G. Experimental data from closed chamber gas uptake studies in rodents suggest lower uptake rate of chemical than calculated from literature values on alveolar ventilation. Arch. Toxicol. 66:1992;291-295.
46. Casciano D.A., Aidoo A., Chen T., Mittelstaedt R.A., Manjanatha M.G., Heflich R.H. HPRT mutant frequency and molecular analysis of HPRT mutations in rats treated with mutagenic carcinogens. Mutat. Res. 431:1999;389-395.
47. S. Osterman-Golkar, Studies on the reaction kinetics of biologically active electrophilic reagents as a basis for risk estimates, Thesis, University of Stockholm, 1975.
48. Aidoo A., Lyn-Cook L.E., Heflich R.H., Olusegun George E., Casciano D.A. The effect of time after treatment, treatment schedule and animal age on the frequency of 6-thioguanine-resistant T-lymphocytes induced in Fischer 344 rats by N-ethyl-N-nitrosourea. Mutat. Res. 298:1993;169-178.
49. Manjanatha M.G., Lyn-Cook L.E., Culp S.J., Beland F.A., Heflich R.H., Aidoo A. Lymphocyte mutant frequency in relation to DNA adduct formation in rats treated with tumorigenic doses of the mammary gland carcinogen 7,12-dimethylbenz[a]anthracene. Mutat. Res. 357:1996;89-96.
50. Skopek T.R., Walker V.E., Cochrane J.E., Craft T.C., Cariello N.F. Mutational spectrum at the HPRT locus in splenic T cells of B6C3F1 mice exposed to N-ethyl-N-nitrosourea. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7866-7870.
51. 6-(2-hydroxyethyl)-2′-deoxyguanosine in DNA of various rat tissues following a single dose of N-nitroso-N-(2-hydroxyethyl)urea. An immunoslotblot study. Carcinogenesis (London). 9:1988;147-151.
52. 6-alkylguanine in HPRT mutagenesis in T-lymphocytes of rats exposed in vivo to ethylmethanesulfonate. N-(2-hydroxyethyl)-N-nitrosourea, or N-ethyl-N-nitrosourea. Cancer Res. 55:1995;1875-1882.
53. Li F., Segal A., Solomon J.J. In vitro reaction of ethylene oxide with DNA and characterization of DNA adducts. Chem. Biol. Interact. 83:1992;35-54.
54. Walker V.E., Craft T.R., Clement N.L., Skopek T.R. In vivo mutagenicity at the HPRT locus in splenic lymphocytes of B6C3F1 mice following parenteral exposures to ethylene oxide. Carcinogenesis. 1999;. submitted.